Vanguard Group Inc Vir Biotechnology, Inc. Transaction History

Vanguard Group Inc

  • $5.46 Trillion
  • Q3 2024

A detailed history of Vanguard Group Inc transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 13,135,956 shares of VIR stock, worth $97.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,135,956
Previous 12,849,217 2.23%
Holding current value
$97.2 Million
Previous $114 Million 13.96%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$7.26 - $10.7 $2.08 Million - $3.07 Million
286,739 Added 2.23%
13,135,956 $98.4 Million
Q2 2024

Aug 13, 2024
BUY
$7.63 - $12.66 $3.62 Million - $6 Million
473,862 Added 3.83%
12,849,217 $114 Million
Q1 2024

May 10, 2024
BUY
$8.6 - $11.9 $672,657 - $930,770
78,216 Added 0.64%
12,375,355 $125 Million
Q4 2023

Feb 14, 2024
BUY
$7.76 - $10.29 $8.51 Million - $11.3 Million
1,096,473 Added 9.79%
12,297,139 $124 Million
Q3 2023

Nov 14, 2023
BUY
$9.14 - $24.62 $8.78 Million - $23.6 Million
960,302 Added 9.38%
11,200,666 $105 Million
Q2 2023

Aug 14, 2023
SELL
$23.2 - $27.29 $628,673 - $739,504
-27,098 Reduced 0.26%
10,240,364 $251 Million
Q1 2023

May 15, 2023
BUY
$22.26 - $30.85 $3.85 Million - $5.34 Million
172,961 Added 1.71%
10,267,462 $239 Million
Q4 2022

Feb 10, 2023
BUY
$19.96 - $28.22 $3.32 Million - $4.69 Million
166,085 Added 1.67%
10,094,501 $255 Million
Q3 2022

Nov 14, 2022
BUY
$18.26 - $31.1 $31.6 Million - $53.8 Million
1,731,172 Added 21.12%
9,928,416 $191 Million
Q2 2022

Aug 12, 2022
BUY
$19.08 - $26.7 $8.37 Million - $11.7 Million
438,847 Added 5.66%
8,197,244 $209 Million
Q1 2022

May 13, 2022
BUY
$21.19 - $40.01 $9.07 Million - $17.1 Million
428,266 Added 5.84%
7,758,397 $200 Million
Q4 2021

Feb 14, 2022
BUY
$30.97 - $54.03 $3.4 Million - $5.93 Million
109,814 Added 1.52%
7,330,131 $307 Million
Q3 2021

Nov 12, 2021
BUY
$34.9 - $54.54 $33.4 Million - $52.3 Million
958,060 Added 15.3%
7,220,317 $314 Million
Q2 2021

Aug 13, 2021
BUY
$38.75 - $51.0 $243 Million - $319 Million
6,262,257 New
6,262,257 $296 Million

Others Institutions Holding VIR

# of Institutions
218
Shares Held
87M
Call Options Held
127K
Put Options Held
1.19M
View Full List

About Vir Biotechnology, Inc.

VIR Quotes by TradingView
  • Ticker VIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 132,638,000
  • Market Cap $982M
  • Description
  • Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...
More about VIR
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email